Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00149006
Status:
UNKNOWN
Last Update Posted:
2007-03-14
First Post:
2005-09-07
Brief Title:
Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 rIL-2 for Metastatic Solid Tumors
Sponsor:
Hadassah Medical Organization
Organization:
Hadassah Medical Organization
Organization Data
Organization:
Hadassah Medical Organization
Class:
OTHER
Study ID:
271296-HMO-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hadassah Medical Organization
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None